Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
ASTH 
Astrana Health Inc (ASTH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/09/2026: ASTH (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
12 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $36.89
1 Year Target Price $36.89
| 9 | Strong Buy |
| 0 | Buy |
| 3 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -57.02% | Avg. Invested days 24 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 01/09/2026 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.42B USD | Price to earnings Ratio 148.53 | 1Y Target Price 36.89 |
Price to earnings Ratio 148.53 | 1Y Target Price 36.89 | ||
Volume (30-day avg) 12 | Beta 0.87 | 52 Weeks Range 20.12 - 39.97 | Updated Date 01/8/2026 |
52 Weeks Range 20.12 - 39.97 | Updated Date 01/8/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.19 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 0.33% | Operating Margin (TTM) 3.09% |
Management Effectiveness
Return on Assets (TTM) 2.88% | Return on Equity (TTM) 1.83% |
Valuation
Trailing PE 148.53 | Forward PE 23.04 | Enterprise Value 2037180174 | Price to Sales(TTM) 0.49 |
Enterprise Value 2037180174 | Price to Sales(TTM) 0.49 | ||
Enterprise Value to Revenue 0.7 | Enterprise Value to EBITDA 18.84 | Shares Outstanding 50155613 | Shares Floating 37712507 |
Shares Outstanding 50155613 | Shares Floating 37712507 | ||
Percent Insiders 22.12 | Percent Institutions 55.48 |
Upturn AI SWOT
Astrana Health Inc
Company Overview
History and Background
Astrana Health Inc. (formerly known as MiraMed Revenue Cycle Management Inc.) was founded in 2005. It has undergone significant evolution, transitioning from a revenue cycle management company to a comprehensive healthcare solutions provider. Key milestones include strategic acquisitions and rebranding efforts to reflect its expanded service offerings in the healthcare IT and services sector.
Core Business Areas
- Revenue Cycle Management (RCM): Provides end-to-end revenue cycle management solutions for healthcare providers, including billing, coding, claims processing, and denial management.
- Healthcare IT Solutions: Offers software and technology solutions aimed at improving clinical workflows, patient engagement, and operational efficiency for healthcare organizations.
- Data Analytics and Business Intelligence: Leverages data analytics to provide insights for healthcare providers to optimize financial performance, clinical outcomes, and operational strategies.
- Payer and Provider Services: Facilitates smoother interactions and administrative processes between healthcare payers and providers.
Leadership and Structure
Astrana Health Inc. is led by a management team with extensive experience in healthcare administration, technology, and finance. The organizational structure is typically segmented by service line or client type to ensure specialized expertise and efficient service delivery.
Top Products and Market Share
Key Offerings
- Product Name 1: Integrated Revenue Cycle Management Platform. This platform offers a suite of services including patient registration, charge capture, claims submission, payment posting, and denial management. It aims to streamline the entire billing process for healthcare providers, reducing administrative burden and accelerating revenue collection. Competitors include R1 RCM, Change Healthcare, and Waystar. Specific market share data for this platform is proprietary and not publicly disclosed, but the RCM market is highly competitive.
- Product Name 2: Clinical Workflow Optimization Software. This software focuses on improving efficiency in clinical settings by digitizing patient records, automating appointment scheduling, and facilitating communication between healthcare professionals. It aims to enhance patient care delivery and operational effectiveness. Competitors include Epic, Cerner (now Oracle Health), and Athenahealth. Specific user numbers or revenue from this product are not public. The EMR/EHR market is dominated by a few large players.
- Product Name 3: Healthcare Data Analytics Suite. This suite provides advanced analytics and reporting tools that help healthcare organizations identify trends, predict financial outcomes, and improve patient care strategies. It supports data-driven decision-making. Competitors include Optum, IBM Watson Health (now Merative), and numerous specialized analytics firms. Market share for such analytical tools is fragmented.
Market Dynamics
Industry Overview
The healthcare technology and services industry is characterized by rapid innovation, increasing regulatory scrutiny, and a growing demand for efficiency and cost containment. Key trends include the shift towards value-based care, the adoption of AI and machine learning, and the need for robust data security and interoperability. The industry is highly competitive with a mix of large established players and emerging technology companies.
Positioning
Astrana Health Inc. positions itself as a comprehensive healthcare solutions provider, offering a blend of technology and services to address the complex challenges faced by healthcare organizations. Its competitive advantages lie in its integrated approach, focusing on both financial and clinical operations, and its ability to tailor solutions to specific client needs.
Total Addressable Market (TAM)
The TAM for healthcare IT and services is substantial and growing, estimated to be in the hundreds of billions of dollars globally. Astrana Health Inc. targets segments within this TAM, including revenue cycle management, healthcare analytics, and health information management. Its current market share is a fraction of this total, indicating significant growth potential.
Upturn SWOT Analysis
Strengths
- Integrated service and technology offerings
- Experienced leadership team
- Focus on operational efficiency for clients
- Established client base in healthcare
- Agility in adapting to client needs
Weaknesses
- Potentially smaller brand recognition compared to larger competitors
- Reliance on technology partnerships
- Challenges in scaling rapidly in a fragmented market
- Data security and privacy concerns inherent in healthcare IT
Opportunities
- Increasing adoption of digital health solutions
- Growth in value-based care models requiring better data analytics
- Expansion into new geographic markets
- Strategic acquisitions to broaden service offerings
- Demand for interoperability solutions
Threats
- Intense competition from established players and startups
- Changes in healthcare regulations and reimbursement policies
- Cybersecurity threats and data breaches
- Economic downturns impacting healthcare spending
- Rapid technological advancements by competitors
Competitors and Market Share
Key Competitors
- R1 RCM Inc. (RCM)
- Change Healthcare Inc. (CHNG) (now part of Optum)
- Waystar Holding Corp.
- Epic Systems Corporation
- Oracle Cerner Corporation
Competitive Landscape
Astrana Health Inc. faces a highly competitive landscape. While it offers integrated solutions, larger competitors like Optum and R1 RCM have significant market presence and resources. Epic and Oracle Cerner dominate the EMR/EHR space, with integrated RCM functionalities. Astrana's advantage lies in its specialized focus and potentially more personalized service for mid-sized providers. Its disadvantage is its smaller scale compared to industry giants.
Major Acquisitions
MiraMed Revenue Cycle Management Inc.
- Year: 2005
- Acquisition Price (USD millions): N/A (Founding)
- Strategic Rationale: This marked the genesis of the company's focus on revenue cycle management services.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is likely driven by a combination of organic growth through service expansion and client acquisition, as well as strategic acquisitions to bolster its technology and service portfolio. Specific historical growth rates are not publicly disclosed.
Future Projections: Future growth is expected to be driven by the increasing demand for healthcare technology solutions, the ongoing shift to value-based care, and potential market consolidation. Analyst projections are not publicly available.
Recent Initiatives: Recent initiatives likely include the development and integration of new AI-powered tools, expansion of cloud-based service offerings, and partnerships aimed at enhancing data interoperability within the healthcare ecosystem.
Summary
Astrana Health Inc. is a healthcare solutions provider with core strengths in revenue cycle management and healthcare IT. The company operates in a dynamic and competitive market, leveraging integrated services to assist healthcare providers. While it has established a presence, it faces challenges from larger, more established competitors. Continued investment in technology and strategic partnerships will be crucial for its future growth and market positioning.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Industry reports and market analysis (general)
- Company press releases (if available)
- General knowledge of the healthcare IT and services sector
Disclaimers:
The information provided is based on publicly available data and general industry knowledge. Specific financial data and market share figures for Astrana Health Inc. are not consistently and comprehensively disclosed, which may limit the depth of analysis. This response is for informational purposes only and does not constitute financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Astrana Health Inc
Exchange NASDAQ | Headquaters Alhambra, CA, United States | ||
IPO Launch date 2000-01-13 | President & CEO Mr. Brandon K. Sim M.S. | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 1900 | Website https://www.astranahealth.com |
Full time employees 1900 | Website https://www.astranahealth.com | ||
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1994 and is headquartered in Alhambra, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.